AI-generated summary
The authors reviewed five preclinical studies on photobiomodulation therapy in diabetic wound healing, focusing on inflammatory cytokines such as interleukin-6, interleukin-1β, and tumour necrosis factor-α. They report that photobiomodulation regulates these cytokine levels and improves cell proliferation and migration, thereby improving wound healing properties. The included studies varied in wavelength, dose, and timing.
- Studies included
- 5
- Who or what was studied
- Preclinical models of diabetic wounds (animal or cell studies; the abstract does not specify)
- Limits stated in the abstract
- The review included only five preclinical studies, which varied in wavelength, dosage, and timing, and the abstract does not report a pooled analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review, Wound healing, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.